# BioLineRx Ltd.: Form 6-K, filed Mar 16, 2022

- Company: [BioLineRx Ltd.](/companies/blrx.md) (CIK 1498403)
- Form: 6-K
- Filed: 2022-03-16
- Accepted by EDGAR: Mar 16, 2022, 11:11 ET
- Period: 2022-03-16
- Accession: 0001178913-22-001132
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1498403/000117891322001132/zk2227490.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1498403/000117891322001132/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1498403/000117891322001132/zk2227490.htm

Filed Mar 16, 2022.
Source: SEC EDGAR, the filing index for accession 0001178913-22-001132. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.
